arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Lantheus Holdings, Inc.

LNTH Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$100.10
▼ -0.3% Today
as of Oct 22, 16:50 ET
Last 30 days -0.22% Sep 14 → Oct 22
$99.41 $99.78 $100.16 $100.53 $100.90 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$99.75
High
$100.34
Low
$99.75
Volume
$1M
Avg Vol
$1M
Mkt Cap
$6.5B
P/E (TTM)
30.03
Beta
—
52w High
$111.86
52w Low
$50.16
Div Yield
—
Shares Out
$65M

Recent Press Releases & News last 60 days · 11 items

Oct 21 · 11:02 GuruFocus.com
ETFs Are Selling Lantheus (LNTH) on Oct. 19
Sep 30 · 12:30 PR GlobeNewswire
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
Sep 28 · 12:58 MT Newswires
Lantheus Doses First Patient in Phase 2/3 Prostate Cancer Trial
▸ Show all 11 press releases & news Free account →

LNTH earnings at a glance

Lantheus Holdings, Inc. (LNTH) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of $1.01, compared with $0.99 in the same quarter last year (+2%). The options market is pricing a move of about ±0.8% after the report, a range of roughly $99.25 to $100.95 from today's $100.10. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±10.7% on average; after the most recent report on Aug 6, 2026 it moved -0.4%. That means options currently expect less movement than LNTH has typically delivered. LNTH beat the consensus EPS estimate in 3 of its last 6 reported quarters. Implied volatility is currently 7%. The share price of $100.10 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$50
$112
81% of range
Avg surprise (last 6)
+11.3%
Avg reaction (last 6)
-8.9%
17% positive
Latest IV / EM
7%
EM ±0.8% · $100 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.04$0.44$0.92$1.40$1.88 Actual $-0.04Actual $1.33Actual $1.88Actual $1.87Actual $0.88Actual $1.79Actual $1.30Est $1.47Actual $1.32Est $1.43Actual $0.99Est $1.05Actual $1.46Est $0.94Actual $1.21Est $1.02Actual $1.32Est $1.11 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$102M$204M$306M$408M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $1.32 $1.11 +18.9% -15.9% -0.4% earnings
Thu May 7, 2026Mar/2026 $1.21 $1.02 +18.6% -6.9% +5.6% earnings
Thu Feb 26, 20268K 2026-02-26 $1.46 $0.94 +55.3% — -0.4% earnings
Thu Nov 6, 2025Sep/2025 $0.99 $1.05 -5.7% — -6.2% earnings
Wed Aug 6, 2025Jun/2025 $1.32 $1.43 -7.7% — -28.6% earnings
Wed May 7, 2025Mar/2025 $1.30 $1.47 -11.6% — -23.2% earnings
Mon Sep 30, 2024Sep 2024 $1.79 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.88 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.87 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.88 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.33 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.04 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER $1.01$0.99 +2.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$388M$377M—$384M$378M$373M—$379M
Cost of revenue$146M$146M—$162M$137M$135M—$137M
Gross profit$242M$231M—$222M$241M$238M—$242M
Operating income$100M$81M—$44M$88M$102M—$134M
Net income$75M$118M—$28M$79M$73M—$131M
EPS (diluted)$1.11$1.80—$0.41$1.12$1.02—$1.79

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$593M$499M$359M$382M$696M$939M$913M$866M
Inventory$58M$61M$65M$62M$62M$69M$68M$71M
Total current assets$1.03B$942M$900M$925M$1.20B$1.42B$1.33B$1.30B
Total assets$2.41B$2.35B$2.23B$2.28B$2.12B$2.06B$1.98B$2.05B
Long-term debt————————
Total liabilities$1.10B$1.13B$1.14B$1.16B$949M$891M$892M$870M
Total equity$1.31B$1.21B$1.09B$1.12B$1.17B$1.16B$1.09B$1.18B

Implied volatility — last 90 days

1%30%59%88%117% Jun 07 — IV 45% · EM ±6.2%Jun 08 — IV 41% · EM ±5.4%Jun 09 — IV 42% · EM ±5.2%Jun 10 — IV 46% · EM ±5.4%Jun 11 — IV 50% · EM ±5.5%Jun 12 — IV 36% · EM ±3.7%Jun 15 — IV 35% · EM ±2.6%Jun 16 — IV 47% · EM ±2.8%Jun 17 — IV 81% · EM ±3.4%Jun 19 — IV 40% · EM ±8.8%Jun 22 — IV 44% · EM ±9.3%Jun 23 — IV 45% · EM ±9.2%Jun 24 — IV 44% · EM ±8.7%Jun 25 — IV 36% · EM ±7.0%Jun 26 — IV 41% · EM ±7.8%Jun 29 — IV 47% · EM ±8.3%Jun 30 — IV 39% · EM ±6.8%Jul 01 — IV 43% · EM ±7.2%Jul 02 — IV 50% · EM ±8.0%Jul 03 — IV 51% · EM ±8.0%Jul 06 — IV 60% · EM ±8.3%Jul 07 — IV 53% · EM ±7.0%Jul 08 — IV 44% · EM ±5.6%Jul 09 — IV 40% · EM ±4.7%Jul 10 — IV 38% · EM ±4.2%Jul 13 — IV 76% · EM ±6.4%Jul 14 — IV 117% · EM ±8.5%Jul 15 — IV 88% · EM ±5.2%Jul 16 — IV 106% · EM ±4.4%Jul 20 — IV 59% · EM ±13.9%Jul 21 — IV 60% · EM ±13.8%Jul 22 — IV 62% · EM ±14.2%Jul 23 — IV 65% · EM ±14.5%Jul 24 — IV 67% · EM ±14.8%Jul 27 — IV 69% · EM ±14.3%Jul 28 — IV 20% · EM ±4.0%Jul 29 — IV 27% · EM ±5.4%Jul 30 — IV 27% · EM ±5.3%Jul 31 — IV 29% · EM ±5.5%Aug 03 — IV 1% · EM ±0.2%Aug 04 — IV 2% · EM ±0.4%Aug 05 — IV 24% · EM ±4.1%Aug 07 — IV 10% · EM ±1.6%Aug 12 — IV 23% · EM ±2.9%Aug 18 — IV 32% · EM ±2.3%Aug 20 — IV 31% · EM ±1.3%Sep 23 — IV 21% · EM ±4.3%Sep 24 — IV 8% · EM ±1.6%Sep 25 — IV 18% · EM ±3.4%Sep 28 — IV 8% · EM ±1.5%Sep 29 — IV 10% · EM ±1.7%Sep 30 — IV 10% · EM ±1.7%Oct 01 — IV 28% · EM ±4.5%Oct 02 — IV 13% · EM ±2.1%Oct 06 — IV 22% · EM ±3.0%Oct 07 — IV 20% · EM ±2.5%Oct 08 — IV 7% · EM ±0.8%

Sector peers

ORKA
Oruka Therapeutics, Inc.
$5.5B $81.15+2.6%
CLDX
Celldex Therapeutics, Inc.
$2.5B $28.97-4.4%
NTLA
Intellia Therapeutics, Inc.
$1.6B $11.16-5.7%
QDEL
QuidelOrtho Corporation
$844M $13.48-5.1%
ACHV
Achieve Life Sciences, Inc.
$745M $6.50-0.1%
TKNO
Alpha Teknova, Inc.
$468M $6.15-16.8%

LNTH earnings FAQ

When is LNTH's next earnings date?

Lantheus Holdings, Inc. is expected to report on November 5, 2026.

What is LNTH's expected move for earnings?

Options currently price a move of about ±0.8%, or $0.85 per share either way from $100.10.

How does LNTH stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.7%, up 1 times and down 5 times.

What EPS are analysts expecting from Lantheus Holdings, Inc.?

The consensus estimate is $1.01 per share, versus $0.99 a year ago.

What is LNTH's implied volatility?

LNTH's at-the-money implied volatility is about 7% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in